ATR and urinary bladder carcinoma: Therefore, restoring the expression of downregulated miRNAs that target ATR, such as miR-27a-3p, miR-143, and miR-205, may enhance cisplatin efficacy and represent a promising strategy to overcome chemoresistance in advanced bladder cancer.